Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), ...

FDA Recall #D-1440-2016 — Class II — December 21, 2015

Recall #D-1440-2016 Date: December 21, 2015 Classification: Class II Status: Terminated

Product Description

Daytrana (methylphenidate transdermal system) Transdermal Patch, 30 mg over 9 hours (3.3 mg/hr), packaged in 30-count patches per box, Rx only, Manufactured by Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5555-3.

Reason for Recall

Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

Recalling Firm

Noven Pharmaceuticals, Inc. — Miami, FL

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

12285 boxes

Distribution

Nationwide

Code Information

Lot #s: 77379, 77380, Exp 05/16; 76944, Exp 03/16

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated